These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30639568)

  • 1. Hypercapnic tumor microenvironment confers chemoresistance to lung cancer cells by reprogramming mitochondrial metabolism in vitro.
    Kikuchi R; Iwai Y; Tsuji T; Watanabe Y; Koyama N; Yamaguchi K; Nakamura H; Aoshiba K
    Free Radic Biol Med; 2019 Apr; 134():200-214. PubMed ID: 30639568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells.
    Cheng MH; Huang HL; Lin YY; Tsui KH; Chen PC; Cheng SY; Chong IW; Sung PJ; Tai MH; Wen ZH; Chen NF; Kuo HM
    Oxid Med Cell Longev; 2019; 2019():6342104. PubMed ID: 31205586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial carrier SLC25A10 regulates cancer cell growth.
    Zhou X; Paredes JA; Krishnan S; Curbo S; Karlsson A
    Oncotarget; 2015 Apr; 6(11):9271-83. PubMed ID: 25797253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria.
    Das S; Das J; Samadder A; Boujedaini N; Khuda-Bukhsh AR
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1433-48. PubMed ID: 23354402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells.
    Blanquer-Rosselló MD; Hernández-López R; Roca P; Oliver J; Valle A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):431-440. PubMed ID: 27760368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Mitochondrial Metabolism Leads to Selective Eradication of Cells Adapted to Acidic Microenvironment.
    Koncošová M; Vrzáčková N; Křížová I; Tomášová P; Rimpelová S; Dvořák A; Vítek L; Rumlová M; Ruml T; Zelenka J
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.
    Montopoli M; Bellanda M; Lonardoni F; Ragazzi E; Dorigo P; Froldi G; Mammi S; Caparrotta L
    Curr Cancer Drug Targets; 2011 Feb; 11(2):226-35. PubMed ID: 21158717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.
    Zhong Y; Li X; Yu D; Li X; Li Y; Long Y; Yuan Y; Ji Z; Zhang M; Wen JG; Nesland JM; Suo Z
    Oncotarget; 2015 Nov; 6(35):37758-69. PubMed ID: 26413751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
    Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
    Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.
    Paul I; Savage KI; Blayney JK; Lamers E; Gately K; Kerr K; Sheaff M; Arthur K; Richard DJ; Hamilton PW; James JA; O'Byrne KJ; Harkin DP; Quinn JE; Fennell DA
    J Pathol; 2011 Aug; 224(4):564-74. PubMed ID: 21706479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer.
    Han Y; Cho U; Kim S; Park IS; Cho JH; Dhanasekaran DN; Song YS
    Free Radic Res; 2018 Dec; 52(11-12):1271-1287. PubMed ID: 29607684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer strategy targeting the energy metabolism of tumor cells surviving a low-nutrient acidic microenvironment.
    Maeda Y; Kikuchi R; Kawagoe J; Tsuji T; Koyama N; Yamaguchi K; Nakamura H; Aoshiba K
    Mol Metab; 2020 Dec; 42():101093. PubMed ID: 33007425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer.
    Chang JC; Chang HS; Wu YC; Cheng WL; Lin TT; Chang HJ; Kuo SJ; Chen ST; Liu CS
    J Exp Clin Cancer Res; 2019 Jan; 38(1):30. PubMed ID: 30674338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cells.
    Su WP; Lo YC; Yan JJ; Liao IC; Tsai PJ; Wang HC; Yeh HH; Lin CC; Chen HH; Lai WW; Su WC
    Carcinogenesis; 2012 Nov; 33(11):2065-75. PubMed ID: 22847181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.
    Wangpaichitr M; Theodoropoulos G; Nguyen DJM; Wu C; Spector SA; Feun LG; Savaraj N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.